Stem Cells Offer New Hope for Parkinson’s Disease Patients  

Sorry, no results.
Please try another keyword

Parkinson’s disease (PD) is a progressive neurodegenerative disorder that affects movement and quality of life. While current treatments like levodopa can provide some symptom relief, they do not stop disease progression. Exciting new research shows stem cell therapy may help slow or reverse PD by regenerating dopamine-producing neurons.

What Causes Parkinson’s Disease?  

In Parkinson’s disease, dopamine-producing neurons in the midbrain area called the substantia nigra pars compacta degenerate and die. This leads to declining levels of the neurotransmitter dopamine in the brain. Dopamine helps control and smooth out body movements, so low levels result in the motor symptoms of PD like tremors, rigidity, and slow movement.

Current Parkinson’s Treatments & Their Drawbacks  

Most current Parkinson’s disease drugs aim to replace lost dopamine, like the standard levodopa/carbidopa (Sinemet). While initially effective for symptoms, the benefits of levodopa tend to decrease over time. Patients can develop drug tolerance, side effects like dyskinesias (involuntary movements), and impulse control issues. When drugs stop providing symptom relief, deep brain stimulation surgery may help some patients.

However, neither levodopa nor deep brain stimulation halt progression or regenerate dopamine neurons. They just attempt to compensate for worsening dopamine deficiency.

How Stem Cells Could Be a Parkinson’s Disease Game-Changer  

Stem cells offer an exciting new potential solution for Parkinson’s disease. Research indicates stem cell therapy may be both neuroprotective—saving existing neurons from dying, and neuroregenerative—creating new dopamine-producing nerve cells to replace those lost in Parkinson’s disease.

Regenerating Dopamine Neurons  

Studies show two types of stem cells—mesenchymal stem cells (MSCs) from umbilical cord tissue and adipose, and olfactory ecto-mesenchymal stem cells from nasal passages—can effectively differentiate into dopamine-producing neurons. When transplanted into the brain, these new cells could replenish dopamine supply.

Stem Cell Transplant Options for Parkinson’s  

Stem cells can be transplanted into the brain through:

  • Intracerebral injection – Injecting stem cells directly into damaged brain regions. This is more invasive and poses some risks.
  • Intrathecal infusion – Delivering cells into the cerebrospinal fluid so they can migrate to affected areas. This is less invasive but cells may not reach intended targets as efficiently.

Research supports both methods. A 2010 study transplanted bone marrow stem cells intracerebrally into PD patients. Three of seven patients showed significant symptom improvements without adverse effects. However, intrathecal infusion is safer and simpler.

Contact the Stem Cell Medical Center in Antigua to learn more about stem cell therapy.

Our experienced doctors provide free consultations to determine if you’re a candidate. We are global leaders in regenerative medicine, to deliver high-quality stem cell treatments safely and effectively. Reclaim your health and quality of life—there is hope!